AUSTIN, Texas, Nov. 11, 2014 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTCQB:BICX), a leader in addiction treatment programs, is now available. The interview can be heard at http://smallcapvoice.com/blog/11-10-14-smallcapvoice-interview-with-biocorrx-inc-bicx
BioCorRx, Inc. announced its financial results for the 3 months ending September, 2014. The full 10-Q filing is available on the SEC's website at http://edgar.sec.gov/
In the interview, Lourdes Felix stated, "What I do want to highlight is for the nine months ended September 30th, our revenues were $802,878. I would like to mention is that there is a progression from quarter to quarter as far as the revenues are concerned for this year. In quarter one we had revenues of roughly $131,000 in quarter two $238,000 and wrapping up quarter three $434,000. So the difference between Q1 and Q2, we have an increase of 82% and from Q2 to Q3 we had an increase of 83%. There is a progression pattern there and that is what we as management had anticipated just from changing the revenue model."
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html or sign up for our FREE newsletter here http://www.smallcapvoice.com/newsletter.html.
About BioCorRx, Inc.
BioCorRx, Inc. (OTCQB:BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX and to sign up for updates from the company please visit www.BICXCorp.com
Click here to view Recent National Television Media on the BioCorRx YouTube Channel
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.